[DOI] [PubMed] [Google Scholar] 239.Zarnowski R, Westler WM, Lacmbouh GA, Marita JM, Bothe JR, Bernhardt J, Lounes-Hadj Sahraoui A, Fontaine J, Sanchez H, Hatfield RD, Ntambi JM, Nett JE, Mitchell AP, Andes DR
Notably, the cardiovascular outcomes study conducted on adults (SELECT study) revealed a higher incidence of hip and pelvic fractures among female patients receiving semaglutide compared to those on placebo: 1.0% (24/2448) versus 0.2% (5/2424) [80]
Good luck to all
2.24.24 Gab said: Thankyou so much for your speedy reply
A recent study showed polyethylene glycol-poly (lactic-co-glycolic acid) (PEGPLGA) nanoencapsulation of EGCG was shown to reduce epidermal thickness from 109.4 m to 43.6 m after 21 days of topical application, accompanied by decreases in lactate dehydrogenase and MDA, and increases SOD, GSH, and T-AOC by 35%60%